Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/1151
Title: Synthesis and characterization of Fe+2, Cu+2 and Ni+2 complexes with thiosemicarbazide-di-ortho-bromobenzylacetone Schiff base and evaluation of their cytotoxicity against breast cancer cells
Other Titles: تحضير وتشخيص معقدات الحديد والنحاس والنيكل الثنائية التكافؤ مع الثايوسيمي كاربازايد – ثنائي اورثو بروموبنزال اسيتون وتقدير فعاليتها ضد خلايا سرطان الثدي
Authors: Haqqi Ismail, Maha
Arif Tawfeeq, Nabeel
Keywords: Divalent metal
Schiff bases
Chalcone
Cytotoxicity
Breast cancer
Issue Date: 2022
Publisher: International Journal of Health Sciences
Abstract: In this study, Schiff base is synthesized through the reactance of di-o-bromobenzylacetone with thiosemicarbazide by acid-catalyzed condensation reaction (Aldol condensation). And using the novel Schiff base to prepare three metal complexes by reacting divalent transition metals (nickel, copper, iron) with the synthesized Schiff base. The prepared compounds were characterized by mass spectrometer, infrared spectrophotometer (FTIR), visible-ultraviolet rays (UV-Vis) and both 1H and 13C nuclear magnetic resonance spectrometer (NMR). The molar conductivity and magnetic susceptibility of the synthesized metal complexes were also measured. The cytotoxicity of the synthesized metal complexes against human breast cancer cell line MDA-MB231 was also measured in-vetro. All of the metal complexes were non-electrolyte and the predicted shape of these metal complexes is tetrahedral geometry. Results obtained from in-vetro cytotoxicity against breast cancer cell line type MDA-MB231 type showed that copper complex had best cytotoxicity with IC50 equal to 18.5µM .
URI: http://localhost:8080/xmlui/handle/123456789/1151
ISSN: ISSN 2550-6978 E-ISSN 2550-696X
Appears in Collections:قسم الكيمياء

Files in This Item:
File Description SizeFormat 
IJHS-12665+3716-3733_220914_222824 - Dr. Nabeel Arif Tawfeeq.pdf812.14 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.